|
UMIN-CTR History |
|
 UMIN-CTR English Home |
Glossary (Simple) |
FAQ |
Search clinical trials |
| Name: | UMIN ID: |
| Unique ID issued by UMIN | UMIN000016782 |
| Receipt No. | R000019475 |
| Scientific Title | An exploratory study of treatment sensitivity and prognostic factors in a Phase III, randomized, controlled study comparing the efficacy and safety of mFOLFOX6 + bevacizumab therapy vs. mFOLFOX6 + panitumumab therapy in patients with chemotherapy-naïve wild-type RAS(KRAS/NRAS) unresectable advanced or recurrent colorectal cancer |
| Date of disclosure of the study information | 2015/03/23 |
| Last modified on | 2017/06/14 19:06:42 |
| No. | Disposal | Last modified on | Item of update | |
| 1 | Insert | 2015/03/11 18:58:19 | ||
| 2 | Update | 2015/03/24 10:22:51 | Last name of contact person Last name of contact person Division name Address Name of person sending information Name of person sending information |
|
| 3 | Update | 2015/03/24 10:24:27 | Email |
|
| 4 | Update | 2015/06/16 12:10:19 | Recruitment status |
|
| 5 | Update | 2015/10/15 19:17:36 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Study ID_2 Org. issuing International ID_2 Org. issuing International ID_2 |
|
| 6 | Update | 2016/09/12 09:04:56 | Name of primary sponsor Organization |
|
| 7 | Update | 2017/06/14 19:06:42 | Recruitment status |
